BlackRock Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$85K Buy
19,951
+8
+0% +$26 ﹤0.01% 3100
2016
Q3
$53K Buy
19,943
+4,976
+33% +$11.4K ﹤0.01% 3231
2016
Q2
$26K Hold
14,967
﹤0.01% 3390
2016
Q1
$35K Hold
14,967
﹤0.01% 3274
2015
Q4
$52K Sell
14,967
-8,240
-36% -$39.5K ﹤0.01% 3179
2015
Q3
$142K Buy
23,207
+705
+3% +$4.78K ﹤0.01% 2926
2015
Q2
$149K Buy
22,502
+6,858
+44% +$46.3K ﹤0.01% 2978
2015
Q1
$111K Buy
+15,644
New +$118K ﹤0.01% 2990

Other funds holding GEN

BlackRock Advisors's GEN Position: Q4 2016 in Review

BlackRock Advisors increased its Genesis Healthcare, Inc. (GEN) stake by 0.04% in Q4 2016, buying an estimated $26 and bringing the position to 19,951 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #3100.

BlackRock Advisors first reported a position in GEN in Q1 2015 and has held it in 8 quarters since. The position peaked at $149K in Q2 2015. 77 funds tracked by Wall St. Rank hold GEN as of Q4 2016.

  • BlackRock Advisors held 19,951 shares of Genesis Healthcare, Inc. worth $85K as of Q4 2016.
  • BlackRock Advisors bought 8 Genesis Healthcare, Inc. shares in Q4 2016, an estimated $26.
  • Genesis Healthcare, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3100 holding.
  • BlackRock Advisors first reported a position in Genesis Healthcare, Inc. in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Advisors's Genesis Healthcare, Inc. position peaked at $149K in Q2 2015.
  • 77 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.